News 2017

Argenx announces collaboration with Broteio Pharma to develop therapeutic antibody for severe autoimmune diseases

Date: 21/03/2017

21 March 2017, Breda, the Netherlands/Ghent, Belgium – argenx (Euronext Brussels: ARGX) today announced that it has entered into a new collaboration with Broteio Pharma B.V. to develop an antibody against a novel target in the complement cascade with therapeutic potential in autoantibody- and complement-mediated indications including autoimmune haemolytic anaemia (AIHA) and antibody mediated rejection (AMR) following organ transplantation. (more…)

Cristal Therapeutics successfully closes €12.8 million financing round

Date: 19/01/2017

19 January 2016, Maastricht, The Netherlands – Cristal Therapeutics today announced the closing of a €12.8 million financing round. The financing comes from a consortium headed by Dutch oncology investor Aglaia BioMedical Ventures and Belgian DROIA Oncology Ventures (more…)

Newspaper articles: Hemics install first Handscan device in Dutch hospital

Date: 10/01/2017

10 January 2017, Eindhoven, The Netherlands – The regional Dutch newspaper Eindhovens Dagblad reported on Hemics installing a first Handscan device in a major Dutch hospital.  (more…)